doi: 10.1210/clinem/dgaa839 12 GuYZhouGZhouFWuQMaCZhangYet al
The risk is highest early in therapy, with significant implications for surgical safety
Like Sermorelin, it is a GHRH analog it stimulates the same pituitary receptor
Furthermore, no studies to date have reported pharmacokinetic parameters (e.g., absorption, bioavailability, tissue distribution), nor have they conducted long-term toxicity assessments or evaluated reproductive outcomes in vivo
With the expected growing number of GLP-1 users, this could have a potential impact of USD 55-90 bn on grocery spending in the US in 2030
Sermorelins human record is decades old and pediatric